Research Article
Diagnostic and Prognostic Potentials of Long Noncoding RNA ELF3-AS1 in Glioma Patients
Table 3
Univariate and multivariate Cox regression analyses of ELF3-AS1 for disease-free survival of glioma patients.
| Variable | Univariate analysis | Multivariate analysis | RR | 95% CI | value | RR | 95% CI | value |
| Age | 1.332 | 0.672-1.989 | 0.223 | — | — | — | <50 vs. ≥50 | | | | | | | Gender | 1.556 | 0.732-2.114 | 0.145 | — | — | — | Male vs. female | | | | | | | WHO grade | 3.183 | 1.327-4.672 | 0.014 | 2.985 | 1.182-4.328 | 0.019 | I–II vs. III–IV | | | | | | | KPS score | 2.987 | 1.247-4.558 | 0.017 | 2.632 | 1.124-4.134 | 0.021 | <80 vs. ≥80 | | | | | | | Extent of resection | 1.561 | 0.767-2.137 | 0.137 | | | | <98% vs. ≥98% | | | | | | | Tumor size (cm) | 1.428 | 0.873-2.018 | 0.233 | — | — | — | <5 vs. ≥5 | | | | | | | ELF3-AS1 expression | 3.213 | 1.327-5.133 | 0.002 | 2.762 | 1.238-4.562 | 0.006 | High vs. low | | | | | | |
|
|